[{"address1": "4660 La Jolla Village Drive", "address2": "Suite 100", "city": "San Diego", "state": "CA", "zip": "92122", "country": "United States", "phone": "650 800 3717", "website": "https://www.revbiosciences.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Revelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. It engages in developing therapeutic product candidates, including GEM-SSI, a potential therapy for the prevention and treatment of surgical sit infection; GEM-AKI, a potential therapy for the prevention and treatment of acute kidney injury; and GEM-CKD, a potential therapy for the prevention and treatment of chronic kidney disease. The company was founded in 2020 and is based in San Diego, California.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Mr. James M. Rolke", "age": 54, "title": "CEO & Director", "yearBorn": 1969, "fiscalYear": 2023, "totalPay": 649250, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Chester Stanley Zygmont III", "age": 43, "title": "CFO & Corporate Secretary", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 479141, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sandra  Vedrick", "title": "Vice President of Human Resources & Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Carol  Odle", "title": "Senior Director of Clinical Projects", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.79, "open": 0.78, "dayLow": 0.78, "dayHigh": 0.8655, "regularMarketPreviousClose": 0.79, "regularMarketOpen": 0.78, "regularMarketDayLow": 0.78, "regularMarketDayHigh": 0.8655, "beta": 0.181, "forwardPE": -0.15341726, "volume": 146166, "regularMarketVolume": 146166, "averageVolume": 1639676, "averageVolume10days": 53900, "averageDailyVolume10Day": 53900, "bid": 0.8115, "ask": 0.8887, "bidSize": 100, "askSize": 100, "marketCap": 3205625, "fiftyTwoWeekLow": 0.702, "fiftyTwoWeekHigh": 25.26, "fiftyDayAverage": 0.9431, "twoHundredDayAverage": 3.11274, "currency": "USD", "enterpriseValue": -10671242, "floatShares": 1638038, "sharesOutstanding": 3758060, "sharesShort": 56568, "sharesShortPriorMonth": 120390, "sharesShortPreviousMonthDate": 1724976000, "dateShortInterest": 1727654400, "sharesPercentSharesOut": 0.0150999995, "heldPercentInsiders": 0.00141, "heldPercentInstitutions": 0.01347, "shortRatio": 0.21, "shortPercentOfFloat": 0.0150999995, "bookValue": 0.694, "priceToBook": 1.2291065, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -15902531, "trailingEps": -36.29, "forwardEps": -5.56, "enterpriseToEbitda": 1.123, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "REVB", "underlyingSymbol": "REVB", "shortName": "Revelation Biosciences, Inc.", "longName": "Revelation Biosciences, Inc.", "firstTradeDateEpochUtc": 1605623400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "f994477e-3690-3dde-965e-6f9faa0f03d6", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.853, "targetHighPrice": 20.0, "targetLowPrice": 8.9, "targetMeanPrice": 14.45, "targetMedianPrice": 14.45, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 2, "totalCash": 12073058, "totalCashPerShare": 7.346, "ebitda": -9502316, "quickRatio": 1.085, "currentRatio": 1.096, "returnOnAssets": -0.42074, "returnOnEquity": -2.53321, "freeCashflow": 834401, "operatingCashflow": -9036168, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-17"}]